Press releases
- Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis
- Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules
- ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS
- Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease
Key statistics
On Friday, Endo International PLC (EO7:FRA) closed at 0.11, 266.67% above the 52 week low of 0.03 set on Oct 31, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.150 |
---|---|
High | 0.150 |
Low | 0.11 |
Bid | -- |
Offer | -- |
Previous close | 0.11 |
Average volume | 8.35k |
---|---|
Shares outstanding | 235.22m |
Free float | 233.36m |
P/E (TTM) | -- |
Market cap | 16.47m USD |
EPS (TTM) | -12.38 USD |
Data delayed at least 15 minutes, as of Mar 31 2023 20:50 BST.
More ▼